MLKL and ovarian cancer: Cell death was alternatively also blocked by inclusion of necrosulfonamide (Figure 2f), which targets the death-inducing RIPK3 substrate, MLKL.18 These results, together, suggest that necroptosis is induced by activation of RIPK1 followed by activation of RIPK3 and MLKL in ovarian cancer cells.